Epetraborole
- Generic Name
- Epetraborole
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C11H16BNO4
- CAS Number
- 1093643-37-8
- Unique Ingredient Identifier
- 6MC93Z2DF9
- Background
Epetraborole has been used in trials studying the treatment of Infections, Bacterial, Infections, Intestinal, Infections, Urinary Tract, and Community-acquired Infection.
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2023-12-21
- Lead Sponsor
- AN2 Therapeutics, Inc
- Target Recruit Count
- 24
- Registration Number
- NCT05995444
- Locations
- ๐บ๐ธ
423001, Tempe, Arizona, United States
Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- AN2 Therapeutics, Inc
- Target Recruit Count
- 314
- Registration Number
- NCT05327803
- Locations
- ๐บ๐ธ
423060, Baltimore, Maryland, United States
๐บ๐ธ423074, Boston, Massachusetts, United States
๐บ๐ธ423079, Cleveland, Ohio, United States
A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function
- First Posted Date
- 2022-03-17
- Last Posted Date
- 2022-07-15
- Lead Sponsor
- AN2 Therapeutics, Inc
- Target Recruit Count
- 40
- Registration Number
- NCT05283746
- Locations
- ๐บ๐ธ
Nucleus Network, Saint Paul, Minnesota, United States
๐บ๐ธAdvanced Pharma CR, Miami, Florida, United States
๐บ๐ธOrlando Clinical Research Center, Orlando, Florida, United States
Phase 1 Study of Epetraborole Tablets
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- AN2 Therapeutics, Inc
- Target Recruit Count
- 51
- Registration Number
- NCT04892641
- Locations
- ๐ฆ๐บ
CMAX Clinical Research, Adelaide, South Australia, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2024. All Rights Reserved by MedPath